Clinical Trial Update: Safety and Tolerability of Novel Medical Nutrition Products for NAFLD Treatment [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update assessing safety and tolerability of novel medical nutrition products for NAFLD/NASH treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Snippet

Sponsor: Russian Academy of Medical Sciences | Conditions: NAFLD, NASH - Nonalcoholic Steatohepatitis | Phase 2, Phase 3 | Status: UNKNOWN